首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1532414

幹細胞製造市場：按類型、按應用、按最終用戶、按地區

Stem Cell Manufacturing Market, By Type, By Application, By End-User, By Geography

出版日期: 2024年07月24日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年，全球幹細胞製造市場將達到128億美元，預計2024年至2031年複合年成長率為13%，到2031年將達到302億美元。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	128億美元
實際資料	2019-2023	預測期	2024-2031
預測 2024-2031 年複合年成長率：	13.00%	2031年價值預測	302億美元

圖：2024 年各地區幹細胞製造市場佔有率（%）

近年來，由於慢性疾病的盛行率不斷上升以及基於幹細胞的治療方法的快速發展，全球幹細胞製造市場經歷了顯著成長。幹細胞具有治療多種退化性疾病和再生受損組織的潛力。此外，製藥公司加大對幹細胞治療和產品開發研發活動的投資也促進了市場成長。然而，與幹細胞治療相關的高成本以及與幹細胞採購相關的倫理問題可能會阻礙市場擴張。

市場動態：

推動全球幹細胞製造市場成長的關鍵因素包括全球慢性疾病的流行、基於幹細胞的成功治療方法數量的增加以及公共和私營部門對幹細胞研究的資金的增加。然而，與幹細胞治療相關的高成本以及與幹細胞採購相關的倫理問題可能會限制市場成長。此外，幹細胞在藥物發現和市場開拓中的廣泛應用預計將在預測期內為市場相關人員提供利潤豐厚的商機。幹細胞療法擴大用於癌症以及各種血液和免疫疾病。根據世界衛生組織的資料，癌症是全球頭號死亡原因，預計光是 2020 年就有約 1,000 萬人死亡。由於乳腺癌、肺癌、結腸癌、直腸癌和前列腺癌是最常見的，市場開拓正在專注於開發用於癌症治療的新幹細胞治療方法。

本研究的主要特點

本報告詳細分析了全球幹細胞製造市場，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
該報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，提供了全球幹細胞製造市場主要企業的概況。
該報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球幹細胞製造市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

公司簡介
- Sartorius
- Becton, Dickinson and Company
- Fujifilm Holdings Corporation（Cellular Dynamics）
- Lonza Group
- Stemcell Technologies
- Corning Incorporated
- Merck Group
- Thermo Fisher Scientific
- Pluristem Therapeutics Inc.
- Miltenyi Biotec
- Takeda Pharmaceutical Company Limited
- DAIICHI SANKYO COMPANY, LIMITED
- AbbVie Inc.
- Bristol-Myers Squibb Company
- GlaxoSmithKline Plc
- Danaher Corporation
- Accegen
- Cellular Engineering Technologies

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5381

Global Stem Cell Manufacturing market is estimated to be valued at USD 12.8 Bn in 2024 and is expected to reach USD 30.2 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 12.8 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	13.00%	2031 Value Projection:	US$ 30.2 Bn

Figure. Stem Cell Manufacturing Market Share (%), By Region 2024

The global stem cell manufacturing market has been witnessing significant growth in the recent past due to the increasing incidence of chronic diseases and rapid advancement in stem cell-based therapies. Stem cells have the potential to treat various degenerative diseases and regeneration of damaged tissues. Moreover, the rising investments by pharmaceutical companies in R&D activities focused on developing stem cell therapies and products is fueling market growth. However, high costs associated with stem cell therapies and ethical issues related to stem cell procurement may hinder the market expansion.

Market Dynamics:

The key drivers spurring the growth of global stem cell manufacturing market include growing prevalence of chronic diseases globally, increasing success of stem cell-based therapies, rising funding from public and private players for stem cell research. However, high costs associated with stem cell therapies and ethical issues related to stem cell procurement may restrain the market growth. Moreover, expanded applications of stem cells in drug discovery and development is expected to present lucrative opportunities for market players over the forecast period. for instance according to WHO In February 2022, increasing awareness of the therapeutic potential of stem cells is fueling market expansion. Stem cell treatments are increasingly used for cancer and various blood and immune disorders. WHO data indicates cancer as a leading cause of death globally, with nearly 10 million deaths in 2020 alone. With breast, lung, colon, rectum, and prostate cancers being the most common, market players are focusing on developing new stem cell therapies for cancer treatment.

Key Features of the Study:

This report provides in-depth analysis of the global stem cell manufacturing market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global stem cell manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Thermo Fisher Scientific, Merck Group, Becton, Dickinson and Company, Lonza Group, Miltenyi Biotec, Takara Bio, STEMCELL Technologies, and PromoCell GmbH.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global stem cell manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Detailed Segmentation-

By Type
- Product
- Services
By Application
- Stem Cell Therapy
- Drug Discovery and Development
- Stem Cell Banking
By End-User
- Biopharmaceutical companies and CRO
- Cell Banks and Tissue Banks
- Academic & Research Institutes
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Sartorius
- Becton, Dickinson and Company
- Fujifilm Holdings Corporation (Cellular Dynamics)
- Lonza Group
- Stemcell Technologies
- Corning Incorporated
- Merck Group
- Thermo Fisher Scientific
- Pluristem Therapeutics Inc.
- Miltenyi Biotec
- Takeda Pharmaceutical Company Limited
- DAIICHI SANKYO COMPANY, LIMITED
- AbbVie Inc.
- Bristol-Myers Squibb Company (US)
- GlaxoSmithKline Plc
- Danaher Corporation
- Accegen
- Cellular Engineering Technologies

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Stem Cell Manufacturing Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Stem Cell Manufacturing Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Product
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Stem Cell Manufacturing Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stem Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Drug Discovery and Development
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Stem Cell Banking
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Stem Cell Manufacturing Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical companies and CRO
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cell Banks and Tissue Banks
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Stem Cell Manufacturing Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Sartorius
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fujifilm Holdings Corporation (Cellular Dynamics)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Stemcell Technologies
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Corning Incorporated
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pluristem Therapeutics Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Miltenyi Biotec
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical Company Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- DAIICHI SANKYO COMPANY, LIMITED
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- GlaxoSmithKline Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Accegen
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cellular Engineering Technologies